[Latest] Global Organ Transplantation Market Size/Share

The Immunosuppressants Global Market Report 2023 by The Business Research Company, provides immunosuppressants market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten-year historic period – 2010-2021, and a ten-year forecast period – 2023-2032.

Learn More On The Immunosuppressants Market:

https://www.thebusinessresearchcompany.com/report/immunosuppressant-global-market-report

According to The Business Research Company’s Immunosuppressants Global Market Report 2023, the global immunosuppressants market size grew from $19.52 billion in 2022 to $22.59 billion in 2023 at a compound annual growth rate (CAGR) of 15.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global immunosuppressants is expected to grow from $38.35 billion in 2027 at a CAGR of 14.1%.

The surge in organ transplant procedures such as kidney and liver transplants due to the rise in incidences of organ failure is the major factor driving the immunosuppressant market’s growth.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=3467&type=smp

The immunosuppressants market is segmented:

1) By Drug Class: Corticosteroids, Monoclonal Antibodies (mAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Other Drug Classes

2) By Indication: Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Phenotypic personalized medicine or PPM or a hybrid of artificial intelligence and physician intervention is a new approach to overcoming the issues with immunosuppressants. For instance, tacrolimus is the most widely used immunosuppressant for patients who are undergoing organ transplantation. When the patient is in the hospital, Tacrolimus immunosuppressant levels must be checked regularly and changed frequently. A PPM approach that is based on a computational platform is used to overcome this concern. The inputs from the computational platform-based PPM approach include the past response of the patient to the dose of the drug and other drugs that are being taken, as well as current data on the liver and kidney. Using PPM, the physician can identify the optimal drug and dose combination from various possibilities. Therefore, it is believed that artificial intelligence is leading the way to not only more personalized and effective drug dosing but also enhancing physicians’ decision-making capabilities by providing clinical data rather than predicted responses.

The immunosuppressants market report table of contents includes: